Navigation Links
Prof. Dr. George Gettinby Honored With Dieter Lutticken Award
Date:5/19/2008

BOXMEER, Netherlands, May 19 /PRNewswire/ -- At the "World Aquaculture 2008", held on May 19-23 in Busan, Korea, Prof. Dr. George Gettinby from the University of Strathclyde, Scotland, United Kingdom, was honored with the Intervet Dieter Lutticken Award for his innovative statistical and epidemiological research methods in sea-lice treatments in salmon farming. The jury found his research methods an excellent example of commitment to the advancement of reducing, refining and replacing the use of animals in research, development and production of veterinary medicines.

Prof. Dr. George Gettinby's research focused on the application of statistical and epidemiological methods in sea-lice treatments in salmon farming in order to minimize the number of animals required in test groups. Gettinby's research also provides an alternative to assessing the effectiveness of veterinary medicines in fish, which supports the replacement principle. This alternative is the adoption of mathematical models which can simulate the effects of treatments on lice populations.

Dr. Dieter Lutticken, who presented the award, with a prize fund of 20,000 Euro said: "There has been a long and intimate relationship between life sciences and statistics. Prof. Gettinby's innovative statistical and epidemiological research methods are an excellent example of refining and reducing the use of animals in sea-lice treatments in salmon farming. I am pleased that we can honor Prof. Gettinby at the World Aquaculture Conference today."

The panel of jury experts praised "Prof. Dr. Gettingby's innovating mathematical model approach for investigating the optimal use of treatments and one which involves minimal use of animals. In addition, these methods also minimize the use of veterinary medicines in the environment."

Prof. Gettinby said: "I am honored to receive the Dieter Lutticken Award and it is pleasing to know that the Award has come as a result of the increasing role of statistics and mathematical modelling in the pursuit of medicines for animals and the improved health of species in aquaculture. In accepting this award, I gratefully acknowledge the collaboration, support and work of the Marine Harvest Ltd, Scottish Quality Salmon, the UK Department for Environment, Food and Rural Affairs and the Epi-informatics research group at the University of Strathclyde."

The Dieter Lutticken award, established in 2004, aims to encourage research into the use of alternative models for animal testing with significant impact on the development or production of new animal health products. Intervet/Schering-Plough Animal Health welcomes submissions from scientists and public life-science institutions. The euro 20,000 award is named after Dr. Dieter Lutticken, a committed researcher in microbiology and virology. He guided and shaped Intervet's R&D for more than a quarter of a century. Dr. Lutticken retired in 2003 from his position as Vice President and Head of R&D.

The award's scope covers in vitro models used in R&D which replace animal testing for licensing purposes as well as studies avoiding the use of animals in efficacy, safety and quality testing in the production of biologicals and pharmaceuticals for animals.

A jury panel composed of experts from public institutions of the animal health/animal testing sector and Intervet representatives looks for possible candidates and makes the final selection. Intervet also welcomes submissions from all life-science research institutions. Commercial organizations are excluded. For more information on applications, please contact Global Communications, Animal Health, Boxmeer, The Netherlands (communications@intervet.com). This year's deadline is November 15, 2008.

Note for the editor

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its website is http://www.schering-plough.com.

For more information about Intervet/Schering-Plough Animal Health visit the following website: http://www.intervet.com http://www.spah.com


'/>"/>
SOURCE Schering-Plough
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Ready: UH prof. chronicles phenomenon of new later motherhood
2. AlphaMed Press Names George Kendall Vice President, Operations and Business Development
3. Georgetown researchers find stem cell marker controls 2 key cancer pathways
4. George Institute receives Gates Foundation grant to survey funding flows
5. Georgetown U student selected for prestigious Bouchet Society
6. Home Oxygen Community Applauds Senator George Voinovich for Joining Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit
7. American Tailgaters Association, ESPNs Sean Salisbury and George Foreman Unite in the Fight Against Pediatric Cancers Around Super Bowl XLII
8. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
9. Photo: MultiVu Promotes George DeTorres to Divisional Vice President for the MultiVu Healthcare Team
10. Cardinal Health Taps Teva Executive George Barrett to Lead Healthcare Supply Chain Services Sector
11. DaVita Nurse Gives Keynote Speech to St. Georges Hospital Vascular Access Annual Meeting in London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... Fort Worth, TX (PRWEB) , ... October 13, ... ... and financial planning agency serving communities in the greater Dallas, Miami, and Raleigh ... a young boy fighting to overcome a rare and deadly chromosome abnormality. , ...
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important to take certain ... inventor from Austin, Texas, has identified a solution. , She developed a prototype for ... lighting. As such, it eliminates the need to turn on a light when taking ...
(Date:10/13/2017)... , ... October 13, 2017 , ... PurhealthRX , ... Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize ... providing a CBD form that can be easily incorporated into liquid products, while reducing ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton ... staged a mock evacuation of the facility as part of a disaster drill on ... Echo Hose EMS and Shelton City Emergency Manager, as well as the Connecticut ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Ellevate Network, the ... business to advocate for action towards gender equality at their inaugural Summit in New ... the globe, and reached a social audience of over 3 million. To watch the ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: ... that developed an innovative way to use nonlinear optical ... delivery of new drugs. ... Dermatology Conference will show how researchers from BioPharmX and ... Medical School used a suite of imaging techniques in ...
(Date:10/10/2017)... Pa. , Oct. 10, 2017   West ... in innovative solutions for injectable drug administration, today shared ... West,s ID Adapter for improving the intradermal administration of ... Fourth Skin Vaccination Summit in May 2017 by Dr. ... Lead, Polio Department, World Health Organization (WHO), and recently ...
(Date:10/4/2017)... , Oct. 4, 2017 OBP ... self-contained, illuminating medical devices, today announced regulatory approval ... Surveillance Agency (or Agência Nacional de Vigilância Sanitária ... single-use, cordless surgical retractor with integrated LED light ... access, illumination and exposure of a tissue pocket ...
Breaking Medicine Technology: